Venus Remedies Quarterly Results for Trading Insights
VENUSREM • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹20 Cr
QSept 2025
Venus Remedies Quarterly Results Key Highlights
- Revenue of ₹195 Cr in Sept 2025 (-3.5% vs Mar 2025, +9.6% vs Sept 2024)
- Net Profit of ₹20 Cr in Sept 2025 (-4.8% vs Mar 2025, +400.0% vs Sept 2024)
- EBITDA of ₹33 Cr in Sept 2025 (-8.3% vs Mar 2025)
- Operating Margin of 16.0% in Sept 2025 (+1.0pp vs Mar 2025)
- Earnings Per Share of ₹15.06 in Sept 2025 (-4.1% vs Mar 2025)
Venus Remedies Quarterly Results Analysis
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | Sept 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 195 | 202 | 141 | 183 | 178 | -3.5% | 9.6% |
| Net Profit (₹ Cr) | 20 | 21 | 10 | 26 | 4 | - | - |
| EBITDA (₹ Cr) | 33 | 36 | 19 | 40 | 16 | - | - |
| EPS (₹) | 15.06 | 15.71 | 7.18 | 19.14 | 2.63 | - | - |
| Operating Margin (%) | 16.0% | 15.0% | 11.0% | 21.0% | 4.0% | - | - |
Venus Remedies Share Price Trend Around Quarterly Results
Visualize Venus Remedies's 1-year price movement across quarterly results — ideal for logging trades in Venus Remedies share price
chart using Tickjournal. All values in ₹.
Related Pages for Venus Remedies
Additional stock information and data for VENUSREM
Revenue Trend (₹ Cr)
Dec 2025
183
Jun 2025
141
Mar 2025
202
Sept 2025
195
Net Profit Trend (₹ Cr)
Dec 2025
26
Jun 2025
10
Mar 2025
21
Sept 2025
20
Operating Margin Trend (%)
Dec 2025
21.0%
Jun 2025
11.0%
Mar 2025
15.0%
Sept 2025
16.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Venus Remedies quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹438,094.57 Cr | 1825.9 | 14,875 | 3,125 | +10.8% | - | 21.0% | 140.5 |
|
Divis Laboratories
Sept 2025 |
₹167,616.86 Cr | 6352.5 | 2,860 | 689 | +7.1% | - | 24.1% | 244.6 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹148,025.88 Cr | 4431.2 | 3,219 | 591 | +11.3% | - | 18.4% | 252.6 |
|
Dr Reddys Laborator…
Sept 2025 |
₹110,630.25 Cr | 1325.5 | 9,135 | 1,337 | +1.1% | - | 14.6% | 81.9 |
|
Cipla
Sept 2025 |
₹107,029.80 Cr | 1329.5 | 7,716 | 1,353 | +12.0% | - | 17.5% | 79.5 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores